Track topics on Twitter Track topics that are important to you
TransEnterix (NYSE:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the second quarter 2018. As quoted in the press release: In the quarter ended June 30, 2018, the Company sold four Senhance Systems, with one … Continued
The post TransEnterix Reports Operating and Financial Results for the Second Quarter 2018 appeared first on Investing News Network.NEXT ARTICLE
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...